264 related articles for article (PubMed ID: 26503964)
1. Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial.
Côté M; Trudel M; Wang C; Fortin A
Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):317-24. PubMed ID: 26503964
[TBL] [Abstract][Full Text] [Related]
2. The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial.
Turcott JG; Del Rocío Guillen Núñez M; Flores-Estrada D; Oñate-Ocaña LF; Zatarain-Barrón ZL; Barrón F; Arrieta O
Support Care Cancer; 2018 Sep; 26(9):3029-3038. PubMed ID: 29550881
[TBL] [Abstract][Full Text] [Related]
3. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
4. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
Davis MP
Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
[TBL] [Abstract][Full Text] [Related]
5. [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].
Pinsger M; Schimetta W; Volc D; Hiermann E; Riederer F; Pölz W
Wien Klin Wochenschr; 2006 Jun; 118(11-12):327-35. PubMed ID: 16855921
[TBL] [Abstract][Full Text] [Related]
6. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
Bottomley A; Tridello G; Coens C; Rolland F; Tesselaar ME; Leemans CR; Hupperets P; Licitra L; Vermorken JB; Van Den Weyngaert D; Truc G; Barillot I; Lefebvre JL
Cancer; 2014 Feb; 120(3):390-8. PubMed ID: 24452673
[TBL] [Abstract][Full Text] [Related]
7. An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting.
Priestman TJ; Priestman SG
Clin Radiol; 1984 Jul; 35(4):265-6. PubMed ID: 6329586
[TBL] [Abstract][Full Text] [Related]
8. An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.
Toth C; Mawani S; Brady S; Chan C; Liu C; Mehina E; Garven A; Bestard J; Korngut L
Pain; 2012 Oct; 153(10):2073-2082. PubMed ID: 22921260
[TBL] [Abstract][Full Text] [Related]
9. A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea.
Priestman SG; Priestman TJ; Canney PA
Clin Radiol; 1987 Sep; 38(5):543-4. PubMed ID: 2822337
[TBL] [Abstract][Full Text] [Related]
10. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
Trials; 2014 Nov; 15():469. PubMed ID: 25432788
[TBL] [Abstract][Full Text] [Related]
11. The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: a prospective cohort study.
Verdonck-de Leeuw IM; Buffart LM; Heymans MW; Rietveld DH; Doornaert P; de Bree R; Buter J; Aaronson NK; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2014 Mar; 110(3):422-8. PubMed ID: 24582144
[TBL] [Abstract][Full Text] [Related]
12. Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life.
Pottel L; Lycke M; Boterberg T; Pottel H; Goethals L; Duprez F; Van Den Noortgate N; De Neve W; Rottey S; Geldhof K; Buyse V; Kargar-Samani K; Ghekiere V; Debruyne PR
Eur J Cancer Care (Engl); 2014 May; 23(3):401-12. PubMed ID: 24467393
[TBL] [Abstract][Full Text] [Related]
13. A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery.
Levin DN; Dulberg Z; Chan AW; Hare GM; Mazer CD; Hong A
Can J Anaesth; 2017 Apr; 64(4):385-395. PubMed ID: 28160217
[TBL] [Abstract][Full Text] [Related]
14. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
Duncan GG; Epstein JB; Tu D; El Sayed S; Bezjak A; Ottaway J; Pater J;
Head Neck; 2005 May; 27(5):421-8. PubMed ID: 15782422
[TBL] [Abstract][Full Text] [Related]
15. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
Ahmedzai S; Carlyle DL; Calder IT; Moran F
Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer.
Kataoka T; Kiyota N; Shimada T; Funakoshi Y; Chayahara N; Toyoda M; Fujiwara Y; Nibu K; Komori T; Sasaki R; Mukohara T; Minami H
Auris Nasus Larynx; 2016 Dec; 43(6):677-84. PubMed ID: 26992271
[TBL] [Abstract][Full Text] [Related]
17. Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial.
Wissel J; Haydn T; Müller J; Brenneis C; Berger T; Poewe W; Schelosky LD
J Neurol; 2006 Oct; 253(10):1337-41. PubMed ID: 16988792
[TBL] [Abstract][Full Text] [Related]
18. Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial.
Pini LA; Guerzoni S; Cainazzo MM; Ferrari A; Sarchielli P; Tiraferri I; Ciccarese M; Zappaterra M
J Headache Pain; 2012 Nov; 13(8):677-84. PubMed ID: 23070400
[TBL] [Abstract][Full Text] [Related]
19. Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial.
Turcotte D; Doupe M; Torabi M; Gomori A; Ethans K; Esfahani F; Galloway K; Namaka M
Pain Med; 2015 Jan; 16(1):149-59. PubMed ID: 25288189
[TBL] [Abstract][Full Text] [Related]
20. Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplastic therapy.
Oliveira KG; von Zeidler SV; Podestá JR; Sena A; Souza ED; Lenzi J; Bissoli NS; Gouvea SA
BMC Cancer; 2014 Jan; 14():39. PubMed ID: 24460780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
